elderbrook solutions GmbH is pleased to announce that it has officially become a member of the German Association of Contract Research Organizations (BVMA – Bundesverband Medizinischer Auftragsinstitute e.V.), effective June, 2026. 

Founded in 1991 and headquartered in Munich, the BVMA is a leading industry association representing contract research organizations (CROs) and related service providers across Germany. The association brings together more than 50 member companies engaged in clinical research at both the national and international levels. 

By joining the BVMA, elderbrook solutions becomes part of a broad network of industry experts, sponsors, and service providers, fostering collaboration and the exchange of best practices across the sector. The company intends to contribute its expertise in biostatistics, clinical data management, statistical programming, and clinical innovation to BVMA initiatives and to support evidence-based discussions on regulatory developments that strengthen Germany as a leading location for clinical research. 

“Our membership in the BVMA reflects our commitment as a growing CRO to actively contribute our expertise to industry initiatives and help shape the future of clinical research,” said Max Horneck, CEO of elderbrook solutions. “We believe that active engagement in industry associations is essential for increasing innovation, promoting a constructive regulatory environment, and ultimately creating greater value for sponsors and patients.” 

The membership further strengthens elderbrook solutions’ position as a strategic, trustworthy and agile partner for biotechnology and pharmaceutical companies seeking high-quality, data-driven clinical development services. 

As the clinical research landscape continues to evolve, elderbrook solutions remains committed to advancing innovation, maintaining the highest standards of quality and compliance, and supporting its clients throughout all stages of clinical development.